Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,544.2
-1.4 (-0.05%)

 

  • STI Straits Times Index
    2,544.2
    -1.4 (-0.05%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,564.7
    -6.9 (-0.44%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    24,890.7
    513.2 (2.11%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,340.3
    -39.0 (-1.15%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,750.2
    420.3 (1.88%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,190.2
    32.3 (0.63%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,407.6M
  • Value: 1,739.9M
  • Rise: 157
  • Fall: 186
  • Unch: 465

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Oceanus^0.008-
Jiutian Chemical0.019+0.002
ThaiBev0.605-
ISDN0.400+0.005
Genting Sing0.675-0.005
Intl Cement0.048+0.023
Polaris0.003-
China Real Estate0.002-
Keppel Corp4.800-0.600
Singtel2.360-0.020

World Indices

World Indices
Name Last Change
Nasdaq 9,757.2 -259.8
HSI 24,265.5 -284.5
HSCEI 9,743.2 -110.0
Jakarta 4,863.1 -41.0
Nikkei 225 22,047.8 -464.2
SSE Comp 2,960.5 -10.1
Shanghai A 3,103.1 -10.6
Shanghai B 211.8 -1.7
KOSPI 2,097.3 -37.3

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

CKLIFE SCIENCES CKLIFE SCIENCES
Quotes 15 Minutes Delayed. Updated at 11 Aug 2020 16:08
Last (HKD): 0.940 Change: -0.010 High: 0.960 Remarks: -
Change (%): -1.05 Low: 0.940
Open 0.960 Yesterday's Close 0.950
Buy Price 0.940 Sell Price 0.940
Buy Volume ('000) 6,422 Sell Volume ('000) 192
Cumulative Volume ('000) 9,897 Cumulative Value 9,395,070
Click to show Stock Prices chart

Key Statistics

EPS (HKD) a 0.01891 Trailing EPS (HKD) e 0.01019 NAV (HKD) b 0.4280
PE a 49.709 Trailing PE f 92.260 Price / NAV b 2.1963
Dividend (HKD) d 0.010000 Cash In Hand (HKD) g 0.0621 Issued & Paid-up Shares c 9,611,070,000
Dividend Yield (%) d 1.064 Price / Cash In Hand g 15.137 Treasury Shares h -
Beta - 75 Daysi 0.649 R-Squared - 75 Days(%)i 11.48 Market Cap (M) 9,034.406
Beta - 500 Daysi 0.817 R-Squared - 500 Days (%)i 1.99 Enterprise Value (M) 14,265.994
Piotroski F Score 5 Exchange Code 775 Par Value ( HKD ) 0.10000
52 Weeks Volatility (%) 121.91 6-Month VWAP 0.965 Free Float (%) 25.0
Sector & Industry Health Technology - Pharmaceuticals: Major
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 29 Jul 2015.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 29 Jul 2015.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference CKLIFE SCIENCES HKEx 9,034.406 49.709 92.260 2.1963 1.064
Industry Pharmaceuticals: Major HKEx 26,791.333 52.716 53.386 3.7392 0.788
Local Peer WUXI APPTEC HKEx 278,434.728 132.638 139.405 14.3546 0.216
Local Peer HANSOH PHARMA HKEx 189,407.680 65.333 65.333 12.9807 -
Local Peer CANSINOBIO-B HKEx 75,246.667 - - 47.4317 -
Local Peer INNOVENT BIO HKEx 70,126.473 - - 13.1811 -
Local Peer SINOPHARM HKEx 59,067.371 8.333 8.333 1.1135 3.295
Local Peer JUNSHI BIO HKEx 46,874.703 - - 15.5653 -
Local Peer SH PHARMA HKEx 42,745.079 9.237 9.237 0.9173 3.200
Local Peer BAIYUNSHAN PH HKEx 36,742.854 10.161 10.987 1.3251 2.854
Local Peer HENLIUS-B HKEx 29,756.351 - - 6.6497 -
Local Peer CHINAGRANDPHARM HKEx 28,999.987 25.197 25.197 3.4626 1.118
Local Peer CHINARES PHARMA HKEx 28,459.770 8.660 8.660 0.6991 2.429
Local Peer HEPALINK HKEx 25,853.738 21.523 28.730 3.0888 0.985
Other Local Peers HYGEIA HEALTH (HKEx), CMS (HKEx), AKESO-B (HKEx), OCUMENSION-B (HKEx), TRAD CHI MED (HKEx), INNOCARE-B (HKEx), UNITED LAB (HKEx), SSY GROUP (HKEx), CSTONE PHARMA-B (HKEx), TONGRENTANGCM (HKEx), HUA MEDICINE-B (HKEx), IMMUNOTECH-B (HKEx), SHINEWAY PHARM (HKEx), TOT BIOPHARM-B (HKEx), FUSEN PHARM (HKEx), CH BIOTECH SER (HKEx), ZHONGZHIPHARM (HKEx), DAWNRAYS PHARMA (HKEx), NEW RAY MEDIC (HKEx), PAK FAH YEOW (HKEx), NC HEALTHCARE (HKEx), CHARMACY PHAR (HKEx), NEP INTERLONG (HKEx), WAI YUEN TONG (HKEx), SANAI HEALTH GP (HKEx), PURAPHARM (HKEx), EXTRAWELL PHAR (HKEx), PASHUN INT'L (HKEx), SINOLIFE UTD (HKEx)
Global Peer JOHNSON & JOHNSON NYSE 389,736.345 25.778 25.666 6.1884 2.533
Global Peer PFIZER INC NYSE 213,328.623 13.110 15.049 3.3159 3.787
Global Peer MERCK & CO INC NYSE 204,640.808 20.791 19.529 7.4032 2.804
Global Peer NOVARTIS AG ADR-EACH REPR 1 CHF0.5(REGD) NYSE 203,261.073 28.839 28.160 3.7773 2.236
Global Peer ABBVIE INC NYSE 163,034.995 20.790 23.621 11.0848 3.982
Global Peer ELI LILLY AND COMPANY NYSE 146,339.910 31.553 26.048 35.7543 1.688
Global Peer ASTRAZENECA SPON ADR EACH REP 0.50 ORD SHS NYSE 145,348.133 108.427 67.519 11.8777 2.474
Global Peer BRISTOL-MYERS SQUIBB CO NYSE 139,337.953 40.517 - 2.8382 2.686
Global Peer SANOFI SPON ADR ECH REP 0.5 ORD SHS NASDAQ 128,184.762 39.397 10.436 1.8029 2.296
Global Peer NOVO NORDISK A/S ADR-EACH CNV INTO 1 CLASS B DKK1 NYSE 117,127.627 20.059 25.660 - 1.760
Other Global Peers GLAXOSMITHKLINE ADR EACH CNV INTO 2 ORD GBP0.25 (NYSE), TAKEDA PHARMACEUTICAL CO LTD SPON ADS EACH REP 0.5 ORD SHS (NYSE), ROYALTY PHARMA PLC (NASDAQ), REPLIGEN CORP (NASDAQ), HUTCHISON CHINA MEDITECH SPON ADS EACH REPR 5 ORD SHS (NASDAQ), GRIFOLS SA SPON ADR EA REPR 1 ORD EUR0.10 (NASDAQ), ALLAKOS INC (NASDAQ), LEGEND BIOTECH CORP SPON ADS EACH REP 2 ORD SHS (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), OPKO HEALTH INC (NASDAQ), BIOHAVEN PHARMACEUTICAL HLDG CO LTD (NYSE), ADC THERAPEUTICS SA (NYSE), REATA PHARMACEUTICALS INC (NASDAQ), PRINCIPIA BIOPHARMA INC (NASDAQ), TURNING POINT THERAPEUTICS INC (NASDAQ), KARUNA THERAPEUTICS INC (NASDAQ), APELLIS PHARMACEUTICALS INC (NASDAQ), SPRINGWORKS THERAPEUTICS INC (NASDAQ), I MAB SPON ADS EACH REP 2.3 ORD SHS (NASDAQ), IGM BIOSCIENCES INC (NASDAQ), Y-MABS THERAPEUTICS INC (NASDAQ), FORMA THERAPEUTICS HLDGS INC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), ZYMEWORKS INC (NYSE), ARCTURUS THERAPEUTICS HOLDINGS INC (NASDAQ), Kimia Farma Tbk. (IDX), KINIKSA PHARMACEUTICALS LTD (NASDAQ), ODONATE THERAPEUTICS INC (NASDAQ), AMNEAL PHARMACEUTICALS INC (NYSE), AKERO THERAPEUTICS INC (NASDAQ), CONSTELLATION PHARMACEUTICALS INC (NASDAQ), AKCEA THERAPEUTICS INC (NASDAQ), PHATHOM PHARMACEUTICALS INC (NASDAQ), QUANTERIX CORPORATION (NASDAQ), GOSSAMER BIO INC (NASDAQ), ARCUTIS BIOTHERAPEUTICS INC (NASDAQ), ATHENEX INC (NASDAQ), REPARE THERAPEUTICS INC (NASDAQ), GENERATION BIO CO (NASDAQ), PETIQ INC (NASDAQ), PHIBRO ANIMAL HEALTH CORP (NASDAQ), KRYSTAL BIOTECH INC (NASDAQ), ANNEXON INC (NASDAQ), ORIC PHARMACEUTICALS INC (NASDAQ), KEROS THERAPEUTICS INC (NASDAQ), PROVENTION BIO INC (NASDAQ), TRICIDA INC (NASDAQ), MIRUM PHARMACEUTICALS INC (NASDAQ), OYSTER POINT PHARMA INC (NASDAQ), NURIX THERAPEUTICS INC (NASDAQ), APREA THERAPEUTICS INC (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), SIGA TECHNOLOGIES INC (NASDAQ), G1 THERAPEUTICS IN (NASDAQ), CALLIDITAS THERAPEUTICS AB SPON ADS EACH REP 2 ORD SHS (NASDAQ), TCR2 THERAPEUTICS INC (NASDAQ), RELMADA THERAPEUTICS INC (NASDAQ), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), CRINETICS PHARMACEUTICALS INC (NASDAQ), FUSION PHARMACEUTICALS INC (NASDAQ), IGBB (Bursa), INOZYME PHARMA INC (NASDAQ), 89BIO INC (NASDAQ), OCULAR THERAPEUTIX INC (NASDAQ), KALA PHARMACEUTICALS INC (NASDAQ), BIOSPECIFICS TECHNOLOGIES CORP (NASDAQ), AC IMMUNE SA (NASDAQ), ORCHARD THERAPEUTICS PLC SPON ADS EACH REPR 1 ORD SHS (NASDAQ), FULCRUM THERAPEUTICS INC (NASDAQ), DURECT CORP (NASDAQ), SATSUMA PHARMACEUTICALS INC (NASDAQ), OVID THERAPEUTICS INC (NASDAQ), IMMUNIC INC (NASDAQ), AMAG PHARMACEUTICS INC (NASDAQ), OSMOTICA PHARMACEUTICALS PLC (NASDAQ), AMRYT PHARMA PLC (NEW) SPON ADS EACH REP 5 ORD SHS (NASDAQ), IMARA INC (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), IDEAYA BIOSCIENCES INC (NASDAQ), BEYONDSPRING INC (NASDAQ), AFT PHARMACEUTICALS LTD (ASX), BSTEAD (Bursa), SUTRO BIOPHARMA INC (NASDAQ), PHARMA (Bursa), STARPHARMA HOLDINGS LIMITED (ASX), HOOKIPA PHARMA INC (NASDAQ), SPERO THERAPEUTICS INC (NASDAQ), MENLO THERAPEUTICS INC (NASDAQ), KALEIDO BIOSCIENCES INC (NASDAQ), LANNETT CO INC (NYSE), BIONDVAX PHARMACEUTICALS SPON ADS REP 40 ORD SHS (NASDAQ), UROVANT SCIENCES LTD (NASDAQ), POLYPID LTD (NASDAQ), PYC THERAPEUTICS LIMITED (ASX), AQUESTIVE THERAPEUTICS INC (NASDAQ), MILESTONE PHARMACEUTICALS INC (NASDAQ), LIQUIDIA TECHNOLOGIES INC (NASDAQ), EVELO BIOSCIENCES INC (NASDAQ), SCPHARMACEUTICALS INC (NASDAQ), VERU INC (NASDAQ), KALVISTA PHARMACEUTICALS INC (NASDAQ), GAMIDA CELL LTD (NASDAQ), THERATECHNOLOGIES INC (NASDAQ), GALERA THERAPEUTICS INC (NASDAQ), LOGICBIO THERAPEUTICS INC (NASDAQ), MUSTANG BIO INC (NASDAQ), NEUBASE THERAPEUTICS INC (NASDAQ), BIOMX INC (NYSE American), TFF PHARMACEUTICALS INC (NASDAQ), SOL GEL TECHNOLOGIES LTD (NASDAQ), AVENUE THERAPEUTICS INC (NASDAQ), LYRA THERAPEUTICS INC (NASDAQ), VERRICA PHARMACEUTICALS INC (NASDAQ), CYCLERION THERAPEUTICS INC (NASDAQ), TYME TECHNOLOGIES INC (NASDAQ), ETON PHARMACEUTICALS INC (NASDAQ), AYALA PHARMACEUTICALS INC (NASDAQ), XERIS PHARMACEUTICALS INC (NASDAQ), OBSEVA SA (NASDAQ),